4,4'-diisothiocyanostilbene-2,2'-disulfonic acid has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aviram, S; Cheng, K; Jhaveri, A; Lan, X; Malhotra, A; Mathieson, PW; Mikulak, J; Saleem, MA; Singhal, PC; Skorecki, K; Wen, H | 1 |
1 other study(ies) available for 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Focal Segmental Glomerulosclerosis
Article | Year |
---|---|
APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Actins; Apolipoprotein L1; Apolipoproteins; Black or African American; Cells, Cultured; Chloride Channels; Chloroquine; Genetic Predisposition to Disease; Genetic Variation; Glomerulosclerosis, Focal Segmental; Humans; Lipoproteins, HDL; Lysosomes; Necrosis; Permeability; Podocytes | 2014 |